MAPT and Alzheimer disease: Emerging evidence suggests that BBB dysfunction occurs in early Alzheimer’s Disease (AD) [1, 2], possibly through interaction between the BBB and neuro-inflammatory mediators within the brain (e.g. β-amyloid, tau) [3–5], or from interaction with systemic inflammatory factors (e.g. resulting from peripheral infection) [6].